See the DrugPatentWatch profile for sivextro
Does Sivextro Contain Sulfa Drugs?
Sivextro (tedizolid phosphate) is a oxazolidinone antibiotic with no sulfonamide components. Its active ingredient, tedizolid, and inactive ingredients like mannitol, sucrose, and sodium lauryl sulfate do not include sulfa (sulfonamide) drugs, which trigger allergies in sensitive patients.[1][2]
Is It Safe for Sulfa-Allergic Patients?
Yes, Sivextro is generally safe for people with sulfa allergies. Clinical data and prescribing information report no cross-reactivity with sulfonamides. No warnings appear in the FDA label regarding sulfa allergy contraindications.[1][3]
What Allergies Should Patients Watch For?
Sivextro carries standard hypersensitivity risks, including rash, anaphylaxis, or severe skin reactions in rare cases (less than 5% incidence in trials). Patients with known allergies to other oxazolidinones like linezolid should avoid it. Discontinue if serious reactions occur.[1][3]
How Does It Compare to Sulfa Antibiotics?
Unlike sulfa drugs (e.g., Bactrim, sulfamethoxazole), Sivextro targets bacterial protein synthesis without sulfone groups that cause allergic responses. It's approved for acute bacterial skin infections, offering an alternative for sulfa-allergic patients needing coverage against MRSA or gram-positives.[1][4]
Key Clinical Evidence on Safety
Phase 3 trials (ESTABLISH-1 and -2) enrolled over 1,300 patients, with no sulfa-related adverse events noted. Post-marketing surveillance confirms low hypersensitivity rates (2-3%), unrelated to sulfonamides.[3][5]
Sources
[1]: Sivextro FDA Label
[2]: Drugs.com - Sivextro Ingredients
[3]: RxList - Sivextro Safety
[4]: Medscape - Tedizolid Overview
[5]: ClinicalTrials.gov - ESTABLISH Trials